Morgan Stanley Discloses Passive Stake in Novavax (NVAX)
Ticker: NVAX · Form: SC 13G · Filed: Feb 9, 2024 · CIK: 1000694
| Field | Detail |
|---|---|
| Company | Novavax Inc (NVAX) |
| Form Type | SC 13G |
| Filed Date | Feb 9, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, SC-13G, passive-investment
TL;DR
**Morgan Stanley just revealed a passive stake in Novavax, signaling institutional interest.**
AI Summary
Morgan Stanley, a major financial institution, reported its ownership of Novavax Inc. (NVAX) common stock as of December 31, 2023. This filing, an SC 13G, indicates that Morgan Stanley holds a significant, but passive, stake in the biotechnology company. This matters to investors because it signals that a large institutional player sees value in Novavax, potentially boosting confidence, but also means a large block of shares could be sold if Morgan Stanley changes its investment strategy.
Why It Matters
Institutional ownership by a firm like Morgan Stanley can lend credibility to a stock, but their passive nature means they aren't actively trying to influence company management.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of institutional ownership and doesn't indicate any immediate negative or positive event for the company.
Analyst Insight
Investors should note Morgan Stanley's passive stake as a sign of institutional interest, but recognize it doesn't imply active management involvement or a strong bullish signal beyond basic ownership.
Key Players & Entities
- Morgan Stanley (company) — the entity filing the SC 13G, disclosing its ownership
- Novavax Inc. (company) — the subject company whose common stock is being reported
- December 31, 2023 (date) — the date of the event requiring the filing, indicating the snapshot of ownership
FAQ
What type of filing is this document?
This document is an SC 13G, filed under the Securities Exchange Act of 1934, specifically Rule 13d-1(b).
Which company is the subject of this filing?
The subject company is NOVAVAX INC, identified by the CUSIP Number 670002401 and Central Index Key (CIK) 0001000694.
Who filed this SC 13G?
This SC 13G was filed by MORGAN STANLEY, with Central Index Key (CIK) 0000895421.
What was the date of the event that triggered this filing?
The date of the event which required the filing of this statement was December 31, 2023.
What class of securities is covered by this filing?
The filing covers 'Common Stock' of Novavax Inc.
Filing Details
This Form SC 13G (Form SC 13G) was filed with the SEC on February 9, 2024 regarding NOVAVAX INC (NVAX).